ÂÜÀòÂÒÂ×

Julie Rudnicki, Ph.D., currently serves as the VP of Clinical Portfolio and Alliance Management at Atomwise, a position held since December 2023. Prior to this, Julie held significant leadership roles at Arvinas, Zentalis Pharmaceuticals, and Ichnos Sciences, advancing programs in critical therapeutic areas. Julie's extensive experience in project management and development spans over two decades, including notable positions at Bayer HealthCare and Boehringer Ingelheim. Julie's academic foundation includes a Ph.D. in Cell Biology and Genetics from Weill Cornell Graduate School of Medical Sciences and a B.S. in Biology with High Honors from Hobart and William Smith Colleges.